Skip to content
Discover insights on emerging technologies, future innovati…

TikTok Content Creators Fueling Unofficial Trade for Unlicensed Slimming Medication

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has taken down violative material and prohibited related keywords and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, positive reviews and step-by-step guides for preparing or administering at home.

After minutes of entering one group, a vendor shared contact information, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly significant health risks”.

The writer

Jason Bautista

A tech futurist and innovation strategist with over a decade of experience analyzing disruptive technologies and their societal impacts.

Journal Future

Type to search articles.